Assessing PK, PD, Safety & Tolerability for Improved Glycaemic Control
Read MoreInsights into Veeda’s Proficiency in Analyzing Peptide Molecules with Precision
Read MoreEvaluating the Safety and Efficacy of Three Different Formulations of Loperamide Hydrochloride
Read MoreLeuprolide Acetate Pharmacokinetic Case Study in Prostate Cancer
Read MoreAssessing Bioequivalence of Risperidone Long-Acting Injectable in Patients with Schizophrenia
Read MoreA Comparative Bioavailability Study of Tiotropium Bromide Inhalation Solution for COPD Management
Read MoreAnalysis of Efficacy and Safety for Anaemia Management in Healthy Volunteers
Read MoreManaging the BE Study Challenges of an Antipsychotic LAI
Read MoreManaging Complexities associated with BE (Bioequivalence) Study of Oncology drug candidate
Read MoreEvaluating the Bioequivalence of Brinzolamide & Brimonidine for the treatment of Open-angle Glaucoma
Read MoreComparative evaluation of Pharmacokinetic & Pharmacodynamic properties to assess Insulin Action for Management of Diabetes
Read MoreVeeda’s successful execution of Pharmacodynamic Characterization of Biosimilar to initiate Phase I clinical trials for the treatment of Rheumatoid Arthritis
Read MoreVeeda’s successful execution of two-way crossover PK study of Inhalation powder in healthy volunteers
Read MoreVeeda’s successful execution of a Phase I, double blinded SAD and MAD study in healthy volunteers treating Vitiligo
Read MoreHow we delivered Quality Results for a leading US-based Pharmaceutical Brand in a record period of 12 days
Read MoreHow we helped an Indian Multinational Pharmaceutical Company reduce Screen Failure Ration significantly
Read MoreA Multinational pharmaceutical company that specializes in development, manufacturing, and distribution
Read MoreAn Indian multinational pharmaceutical company was planning the marketing approval in the EU for Schizophrenic patients.
Read MoreA specialty pharmaceutical company based in USA that specializes in development, manufacturing, and Commercialization
Read MoreGain insights into our capabilities in supporting 505(b)(2) applications and complex generics development
Read More